愛污传媒

Skip to main content

Canadian-founded company develops first AI-designed COVID-19 drug, starts clinical trials

Share

For the first time ever, a drug for COVID-19 designed with artificial intelligence is headed to clinical trials.

Insilico Medicine, a Hong Kong-based AI pharmaceutical company, announced last Thursday its ISM3312 therapeutic would be starting clinical trials in China after its preclinical studies found that the drug "significantly reduces" viral load and inflammation in the lungs.

 鈥淕enerative AI is transforming every area of human development,鈥 Alex Zhavoronkov, Insilico's Canadian founder and CEO, . 鈥淲e鈥檙e extremely happy to announce that our second small molecule therapeutic generated using generative AI is now entering human clinical trials and there is a very clear timeline to demonstrate the discovery and development cycle.鈥

The drug works by inhibiting enzymes in the virus known as proteases by irreversibly binding to them. The particular protease it targets is called 3CLpro, the main protease found in the SARS-CoV-2 virus.

"The target is a great target. The beauty of it is that this protease that is targeted, it's very dissimilar of those that we in the human body actually have, so it's a good target," Oxford University's Dr. Peter Juni, former head of the Ontario Science Table, told CTV's Your Morning on Tuesday.

Insilico leveraged AI in order to develop and test a molecule that can bind and inhibit the protease by fitting into its pockets. This molecule would then become the basis of the drug.

"What AI is really good at is detecting patterns and then basically make use of these patterns to develop a drug or a molecule that fits into certain pockets," Juni explained. "AI doesn't care about our conventions that we have scientists. It just recognizes patterns and tries to find the best fit."

Currently, the drug treatment options for COVID-19 include prescription antivirals like Paxlovid and Evusheld, but Insilico researchers note that these drugs may be ineffective at treating future variants of the virus. The U.S. Food and Drug Administration has already pulled its authorization for Evusheld, citing its inefficacy in treating certain variants of COVID-19.

But similar proteases to the one that ISM3312 targets are found in all coronaviruses, meaning that the drug could be effective at not only targeting current and future variants of SARS-CoV-2, but other coronaviruses as well.

However, despite its potential, Juni says it's too early to tell if the drug will be a success.

"It's a good start but there's a long time to go until we know whether it's safe in humans, and whether it actually works," he said.

CTVNews.ca Top Stories

BREAKING

BREAKING

Montreal police say four teenagers suffered stab wounds after an altercation near John F. Kennedy High School in the city's Villeray鈥擲aint-Michel鈥擯arc-Extension borough on Thursday.

The Maritime Sikh Society says the body of a young employee who died at a Walmart in Halifax last weekend was found by her mother.

Four people are dead and another is in hospital after a Tesla driving through downtown Toronto at a high rate of speed crashed into a guardrail and struck a concrete pillar on Lake Shore Boulevard.

It's a dream for many Canadians, trying to save up enough money for a down payment on their very first home. That was also the dream for the Esmeralda family, a family of five with two dogs who currently live in a Scarborough apartment building.

The RCMP is warning residents in northeast Saskatchewan to seek shelter and avoid picking up hitchhikers as police search for a group of armed and dangerous suspects.

Local Spotlight

A new resident at a Manitoba animal rescue has waddled her way into people's hearts.

Hundreds of people ran to the music of German composer and pianist Beethoven Wednesday night in a unique race in Halifax.

He is a familiar face to residents of a neighbourhood just west of Roncesvalles Avenue.

A meteor lit up our region's sky last night 鈥 with a large fireball shooting across the horizon over Lake Erie at around 7:00 p.m.

Residents of Ottawa's Rideauview neighbourhood say an aggressive wild turkey has become a problem.

A man who lost his life while trying to rescue people from floodwaters, and a 13-year-old boy who saved his family from a dog attack, are among the Nova Scotians who received a medal for bravery Tuesday.

A newly minted Winnipegger is hoping a world record attempt will help bring awareness for the need for more pump track facilities in the city.

A Springfield, Ont. man is being hailed a 'hero' after running into his burning home to save his two infant children.

Hortense Anglin was the oldest graduate to make her way across the platform at York University's Fall Convocation ceremony this week. At the age of 87, she graduated with an Honours degree in Religious Studies.

Stay Connected